Repligen Corp COO James Bylund Sells 4,373 Shares [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Filing . The transaction was executed at an average price of $198.08 per share, resulting in a total value of $866,073.84. Warning! GuruFocus has detected 2 Warning Sign with PDFS. Repligen Corp is a bioprocessing company that focuses on the development, manufacture, and commercialization of products used in the process of drug manufacturing. The company's products include protein A ligands, cell culture growth factors, chromatography equipment, and filtration products, which are essential for the production of biologic drugs. Over the past year, the insider has sold a cumulative total of 4,373 shares and has not made any purchases of the stock. The insider transaction history for Repligen Corp shows a pattern of more sales than purchases among insiders, with 1 insider buy and 3 insider sells over the past year. On the valuation front, Repligen Corp's shares were trading at $198.08 on the day of the insider's sale, giving the company a market capitalization of $10.696 billion.
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Repligen First Quarter 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Repligen Co. (NASDAQ: RGEN) had its price target lowered by analysts at JPMorgan Chase & Co. from $230.00 to $200.00. They now have an "overweight" rating on the stock.MarketBeat
- Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Repligen (RGEN) Misses Q1 Earnings Estimates [Yahoo! Finance]Yahoo! Finance
RGEN
Earnings
- 5/1/24 - Miss
RGEN
Sec Filings
- 5/3/24 - Form DEFA14A
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- RGEN's page on the SEC website